Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarget Healthc. Regulatory News (THRL)

Share Price Information for Target Healthc. (THRL)

Share Price is delayed by 15 minutes
Get Live Data
110.60    -1.00 (-0.90%)
Bid:
110.40
Ask:
110.80
Spread: 0.40 (0.362%)
Market Cap: £685.98m
THRL Live PriceLast checked at - London Stock Exchange

Intraday Target Healthc. Share Chart

Edison issues update on Target Healthcare REIT

11 Aug 2023 08:09

RNS Number : 0744J
Target Healthcare REIT PLC
11 August 2023
 

London, UK, 11 August 2023

 

Edison issues update on Target Healthcare REIT (THRL)

Target Healthcare REIT's Q423 shows a second consecutive quarter of NAV growth, as property yields stabilise and indexed rent uplifts drive valuation growth. Rental growth and near-full rent collection are supporting earnings and delivering full dividend cover. Audited full year results will be published in early October.

 

The current, rebased annualised rate of quarterly DPS through H223 (5.6p), fully covered on a run-rate basis, reflects an attractive prospective yield of 7.7% and is a base from which to grow. We forecast 3.6% growth in FY24. Meanwhile, the discount to end-FY23 NAV is c 30%.

 

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first company in-market 17 years ago, Edison has more than 100 employees and covers every economic sector. Headquartered in London, Edison also has offices in New York, Sydney and Wellington.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Martyn King +44 (0)20 3077 5700 financials@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFIFIDTFILLIV
Date   Source Headline
19th Jun 202612:12 pmRNSHolding(s) in Company
6th May 20267:00 amRNSNet Asset Value, Corporate Update & Dividend
18th Mar 20267:00 amRNSHalf-year Report
16th Mar 202612:00 pmRNSInvestor Presentation via Investor Meet Company
16th Mar 202612:00 pmRNSInvestor Presentation via Investor Meet Company
12th Mar 20267:00 amRNSNotice of Half Year Results
24th Feb 20267:00 amRNSHolding(s) in Company
5th Feb 20267:00 amRNSNet Asset Value, Corporate Update & Dividend
24th Dec 20257:00 amRNSHolding(s) in Company
5th Dec 20257:00 amRNSResult of AGM
1st Dec 20257:00 amRNSAcquisition of care homes and forward commitment
4th Nov 20257:00 amRNSNet Asset Value, Corporate Update & Dividend
31st Oct 202510:00 amRNSAnnual Financial Report
17th Oct 20257:00 amRNSInvestor Presentation via Investor Meet Company
14th Oct 20257:00 amRNSFinal Results
8th Oct 20254:08 pmRNSHolding(s) in Company
6th Oct 20257:00 amRNSNotice of Full Year Results
25th Sep 20257:00 amRNSDisposal of homes, debt refinancing & pipeline
2nd Sep 20257:00 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSHolding(s) in Company
20th Aug 20254:42 pmRNSHolding(s) in Company
20th Aug 20257:00 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSNet Asset Value, Corporate Update & Dividend
30th Jul 202511:01 amRNSHolding(s) in Company
8th May 20257:00 amRNSNet Asset Value, Corporate Update & Dividend
10th Apr 20254:00 pmRNSHolding(s) in Company
26th Mar 20257:00 amRNSInvestor Presentation via Investor Meet Company
14th Mar 20257:00 amRNSHalf-year Report
11th Mar 20254:30 pmRNSNotice of Half Year Results
5th Mar 20257:00 amRNSAppointment of Joint Broker
3rd Mar 20254:20 pmRNSHolding(s) in Company
10th Feb 202511:21 amRNSHolding(s) in Company
5th Feb 20257:00 amRNSNet Asset Value, Corporate Update & Dividend
23rd Jan 20253:42 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSResult of AGM
29th Oct 20247:00 amRNSNet Asset Value, Corporate Update & Dividend
23rd Oct 202410:00 amRNSAnnual Financial Report
18th Sep 20247:00 amRNSInvestor Presentation via Investor Meet Company
17th Sep 20247:00 amRNSFinal Results
12th Sep 20249:00 amRNSNotice of Full Year Results
6th Aug 20247:00 amRNSNet Asset Value, Corporate Update & Dividend
27th Jun 20247:00 amRNSDisposal of four care homes for £44.5 million
20th May 202412:09 pmEQSEdison issues update on Target Healthcare REIT (THRL): Positive momentum continued in Q3
9th May 20247:00 amRNSNet Asset Value, Corporate Update & Dividend
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSHalf-year Report
8th Mar 20249:00 amRNSInvestor Presentation via Investor Meet Company
22nd Feb 20247:00 amRNSNotice of Half Year Results
6th Feb 20242:00 pmEQSEdison issues update on Target Healthcare REIT (THRL): Rent cover at a high and fully covered DPS
1st Feb 20247:00 amRNSNet Asset Value, Corporate Update & Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.